Description

Book Synopsis
The development of gene edited cell therapies: challenges and solutions .- Combined advanced therapies: challenges and solutions.- Developing advanced therapies in a challenging patent and legal environment: perspectives on current and future cell therapies .-  Developing Ethical perspectives on advanced therapies and future challenges .- Modelling adequate reimbursement for cell therapies .- Facilitating international coordination of manufacturers and regulators .- The future of reference materials for cell therapies .- Experiences Development of ISO standards for cell therapies .- NIST activities in development of standards for cell therapies .- FIRM and Japanese standardization initiative for regenerative medicine .- The industry perspective: ARM SBC and ASTM  .- Development of cell therapy regulation: the Japanese experience.- MFDS and Korean regulation .- Australian approaches to regulation .- EU regulatory processes for cell therapy applications .- Canadian cell therapyregs .- Development of cell therapy regulation: the US perspective.


Cell Therapy Manufacturing

    Product form

    £134.99

    Includes FREE delivery

    RRP £17,999.00 – you save £17,864.01 (99%)

    Order before 4pm today for delivery by Fri 3 Jul 2026.

    A Hardback by Glyn Stacey

    1 in stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Cell Therapy Manufacturing by Glyn Stacey

      Publisher: Springer
      Publication Date: 9/18/2025
      ISBN13: 9783031972966, 978-3031972966
      ISBN10: 3031972961
      Also in:
      Developmental biology

      Description

      Book Synopsis
      The development of gene edited cell therapies: challenges and solutions .- Combined advanced therapies: challenges and solutions.- Developing advanced therapies in a challenging patent and legal environment: perspectives on current and future cell therapies .-  Developing Ethical perspectives on advanced therapies and future challenges .- Modelling adequate reimbursement for cell therapies .- Facilitating international coordination of manufacturers and regulators .- The future of reference materials for cell therapies .- Experiences Development of ISO standards for cell therapies .- NIST activities in development of standards for cell therapies .- FIRM and Japanese standardization initiative for regenerative medicine .- The industry perspective: ARM SBC and ASTM  .- Development of cell therapy regulation: the Japanese experience.- MFDS and Korean regulation .- Australian approaches to regulation .- EU regulatory processes for cell therapy applications .- Canadian cell therapyregs .- Development of cell therapy regulation: the US perspective.


      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account